Zobrazeno 1 - 10
of 130
pro vyhledávání: '"G, Grimfors"'
Autor:
Eva Kimby, Jan Liliemark, Magnus Björkholm, Astrid Gruber, Andreas Killander, Gunnar Juliusson, M. Järnmark, G. Grimfors, R. Hast, G. Gahrton
Publikováno v:
European Journal of Haematology. 55:19-23
Complex-binding of anthracyclines to DNA may increase their therapeutic efficacy. In a previous randomized trial patients with acute myelocytic leukaemia (AML) receiving combination chemotherapy including a DNA-bound doxorubicin preparation had a lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0109d585616cab906d89165bc468a1
https://doi.org/10.1111/j.1600-0609.1995.tb00228.x
https://doi.org/10.1111/j.1600-0609.1995.tb00228.x
Autor:
Håkan Mellstedt, Gunnar Juliusson, Eva Ösby, Bengt Simonsson, Bengt Smedmyr, C. Paul, B. Wadman, Bertil Johansson, Erik Svedmyr, H. Strander, Magnus Björkholm, M. Björeman, H. Gyllenhammar, Andreas Killander, Karl Merk, G. Brenning, G. Grimfors, G. Gahrton, A.-M. Stalfelt, Eva Kimby, Richard A. Lerner, M. Järnmark, A.-M. Udén, Anders Österborg, R. Hast
Publikováno v:
European Journal of Haematology. 43:124-128
A randomized study comparing melphalan/prednisone (M/P) therapy with MP + natural alpha-IFN in untreated patients with multiple myeloma stages II and III started April 1, 1986. By March 1989, 78 patients were evaluable in the MP group and 80 in the M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d65561e3fc0b7d41c6c86c06ff099e
https://doi.org/10.1111/j.1600-0609.1989.tb01504.x
https://doi.org/10.1111/j.1600-0609.1989.tb01504.x
Autor:
Ulla Axdorph, Magdalena Czader, Lambert Skoog, Edneia Tani, Ola Landgren, Anna Porwit MacDonald, C. Wedelin, G. Grimfors, Åke Öst, Erik Svedmyr, Magnus Björkholm
Publikováno v:
The Hematology Journal. 5:69-76
Introduction: Surgical biopsy examination is the gold standard for lymphoma diagnostics. However, fine-needle aspiration cytology (FNAC) offers several advantages in that it is quick, inexpensive, and the aspiration procedure has very few complicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d9abfd660c47ed015b4952f90e75d5
https://doi.org/10.1038/sj.thj.6200316
https://doi.org/10.1038/sj.thj.6200316
Autor:
Gunnar Öberg, G. Gahrton, Richard A. Lerner, Astrid Gruber, C. Paul, A.-M. Stalfelt, Ulf Tidefelt, Magnus Björkholm, G. Grimfors, Bengt Simonsson, S. Mattson, A.-M. Udén, Robert Hast, Leif Stenke, Jan Liliemark, M. Björeman, Andreas Killander
Publikováno v:
European Journal of Haematology. 68:376-381
It is still controversial how to treat elderly patients with acute myeloid leukaemia (AML), and results have been poor with most regimens. We report the long-term results of a randomised study performed by the Leukaemia Group of Middle Sweden during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71cb222d566d088b061f4161ab0bd95e
https://doi.org/10.1034/j.1600-0609.2002.00423.x
https://doi.org/10.1034/j.1600-0609.2002.00423.x
Autor:
Ulla Axdorph, Håkan Mellstedt, Göran Holm, Magnus Björkholm, E. Svedmyr, Ola Landgren, G. Grimfors, K. Merk, B. Johansson
Publikováno v:
Annals of Oncology. 6:895-899
Background : The optimal number of chemotherapy courses in responding patients with advanced-stage Hodgkin's disease (HD) is unknown. Patients and methods : With minimizing chemotherapy and thereby reducing late complications as the objective, patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5cd781f388e8db4eb428ea4191d4a67
https://doi.org/10.1093/oxfordjournals.annonc.a059356
https://doi.org/10.1093/oxfordjournals.annonc.a059356
Autor:
G. Holm, Håkan Mellstedt, G. Grimfors, Erik Svedmyr, Magnus Björkholm, Owe Tullgren, C. Wedelin, Bertil Johansson, Karl Merk
Publikováno v:
Cancer. 68:768-775
Two hundred sixty-two adult patients with Hodgkin's disease (HD) were studied. Incorporation of carbon-14-thymidine was measured in unstimulated monocyte-depleted lymphocyte cultures, and in cultures activated by concanavalin A (Con-A) before institu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::580dd9cadec678638317c03cb8b38e69
https://doi.org/10.1002/1097-0142(19910815)68:4<768::aid-cncr2820680418>3.0.co
https://doi.org/10.1002/1097-0142(19910815)68:4<768::aid-cncr2820680418>3.0.co
Publikováno v:
Blood. 76:583-589
Untreated patients with Hodgkin's disease (HD) have a blood T- lymphocytopenia mainly caused by a reduction of the CD4+ subset. Indirect support for a sequestration of T cells in the spleen and tumor- involved lymphoid tissue has accumulated. To test
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0372c4352ea366b9a40e6eb68931594a
https://doi.org/10.1182/blood.v76.3.583.bloodjournal763583
https://doi.org/10.1182/blood.v76.3.583.bloodjournal763583
Autor:
Susanne Widell, Shahideh Rezai, Eva Johansson, Magnus Björkholm, G. Grimfors, Per Engervall, Ola Landgren
Publikováno v:
European journal of haematology. 77(1)
Splenectomy may lead to a good response in 60-80% of adult patients with corticosteroid refractory idiopathic thrombocytopenic purpura (ITP) but, the long-term response to splenectomy still remains less well defined. We assessed the long-term efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a7796b971a19b1518ee4558aa646544
https://pubmed.ncbi.nlm.nih.gov/16573739
https://pubmed.ncbi.nlm.nih.gov/16573739
Autor:
G, Oberg, A, Killander, M, Björeman, G, Gahrton, G, Grimfors, A, Gruber, R, Hast, R, Lerner, J, Liliemark, S, Mattson, C, Paul, B, Simonsson, A-M, Stalfelt, L, Stenke, U, Tidefelt, A-M, Udén, M, Björkholm
Publikováno v:
European journal of haematology. 68(6)
It is still controversial how to treat elderly patients with acute myeloid leukaemia (AML), and results have been poor with most regimens. We report the long-term results of a randomised study performed by the Leukaemia Group of Middle Sweden during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dfc292e903068aae72df282b2272bba1
https://pubmed.ncbi.nlm.nih.gov/12225396
https://pubmed.ncbi.nlm.nih.gov/12225396
Autor:
Jan Sjöberg, Ulla Axdorph, Magnus Björkholm, Anna Porwit-MacDonald, G. Grimfors, Ola Landgren
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 11(11)
The International Prognostic Score (IPS) identifies seven independent factors predicting progression-free and overall survival in advanced stage Hodgkin's disease (HD). The IPS is also applicable in limited disease. However, the IPS does not identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50151748da3481577e6d1b2cf2d96ed7
https://pubmed.ncbi.nlm.nih.gov/11142480
https://pubmed.ncbi.nlm.nih.gov/11142480